Inhibitors of bradykinin-inactivating enzymes decrease myocardial ischemia/reperfusion injury following 3 and 7 days of reperfusion

Journal of Pharmacology and Experimental Therapeutics

Volumn 298, Issue 3, 2001, Pages 970-975

  Schriefer, J A ^a   Broudy, E P ^a   Hassen, A H ^a  

^a WEST VIRGINIA SCHOOL OF OSTEOPATHIC MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ INACTIVATING ENZYME INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIN CONVERTING ENZYME; ENZYME INHIBITOR; ICATIBANT; MEMBRANE METALLOENDOPEPTIDASE; N (1 CARBOXYPHENYLPROPYL)ALANYLALANYLPHENYLALANYL 4 AMINOBENZOATE; N (1 CARBOXYPHENYLPROPYL)PHENYLALANYL 4 AMINOBENZOATE; NITRIC OXIDE; RAMIPRILAT; THIMET OLIGOPEPTIDASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME INHIBITION; FEMALE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; REPERFUSION INJURY;

4-AMINOBENZOIC ACID; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BRADYKININ; FEMALE; HEART VENTRICLES; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; OLIGOPEPTIDES; PHENYLALANINE; PROTEASE INHIBITORS; RABBITS; RAMIPRIL; SEX CHARACTERISTICS; TIME FACTORS;

EID: 0034892994     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Membrane-bound kidney neutral metalloendopeptidase: Interactions with synthetic substrates, natural peptides, and inhibitors
2. Nitric oxide inhibition improved myocardial metabolism independent of tissue perfusion during ischemia but not during reperfusion
3. Angiotensinconverting enzyme inhibitor ramiprilat interferes with the sequestration of the B2 kinin receptor within the plasma membrane of native endothelial cells
4. Contribution of angiotensin-converting enzyme to the cardiac metabolism of bradykinin: An interspecies study
5. Evidence that enzymatic conversion of N-[1(R,S)carboxy-3-phenylpropyl]-Ala-Ala-Phe-p-aminobenzoate, a specific inhibitor of endopeptidase 24.15, to N-[1(R,S)-carboxy-3-phenylpropyl]-Ala-Ala is necessary for inhibition of angiotensin converting enzyme
6. Pharmacology and cardiovascular implications of the kinin-kallikrein system
7. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: Effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels
8. Potentiation of bradykinin actions by ACE inhibitors
9. Cardioprotective effects of the aminopeptidase inhibitor apstatin: Studies on ischemia/reperfusion injury in the isolated rat heart
10. Angiotensin-(1-7): A bioactive fragment of the renin-angiotensin system
11. Angiotensin 1-7 induces bradykininmediated relaxation in porcine coronary artery
12. Reperfusion injury induces apoptosis in rabbit cardiomyocytes
13. Reduction of myocardial infarct size by ramiprilat is independent of angiotensin-II synthesis inhibition
14. Inhibition of nitric oxide synthase prevents myocardial protection by ramiprilat
15. Reduction of myocardial infarct size in rabbits by ramiprilat: Reversal by the bradykinin antagonist HOE140
16. Reperfusion induced injury: Manifestations, mechanisms, and clinical relevance
17. Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system
18. Endopeptidase 24.15 inhibition and opioid antinociception
19. Changes in bradykinin level in coronary sinus blood after the experimental occlusion of a coronary artery
20. Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide
21. Role of kinins in the pathophysiology of myocardial ischemia. In vitro and in vivo studies
22. Reduction of infarct size by local angiotensin converting enzyme inhibition is abolished by a bradykinin receptor antagonist
23. The possible role of bradykinin in the antiischemic activity of ACE-inhibitors
24. Captopril increases the affinity of bradykinin receptor binding sites in bovine coronary arterial endothelial cells
25. Intracoronary L-arginine during reperfusion improves endothelial function and reduces infarct size
26. A local kallikreinkinin system is present in rat hearts
27. A soluble metalloendopeptidase from rat brain. Purification of the enzyme and determination of specificity with synthetic and natural peptides
28. Substrate-related potent inhibitors of brain metalloendopeptidase
29. Angiotensin-(1-7) potentiates the hypotensive effect of bradykinin in conscious rats
30. Bradykinin metabolism in the postinfarcted rat heart: Role of ACE and neutral endopeptidase 24.11
31. Molecular modeling of the active site of endothelin-converting enzyme
32. Endopeptidase inhibitors decrease myocardial ischemia/reperfusion injury in an in vivo rabbit model
33. Modulatory effect of endopeptidase inhibitors on bradykinin-induced contraction of rat uterus
34. Molecular pharmacology of endothelin converting enzymes
35. Role of bradykinin in myocardial preconditioning
36. Endopeptidase 3.2.24.11 converts N-1-(R,S)carboxy-3-phenylpropyl-Ala-Ala-Phe-p-carboxyanilide into a potent inhibitor of angiotensin-converting enzyme
37. Effect of neutral endopeptidase 24.11 inhibition on myocardial ischemia/reperfusion injury: The role of kinins
38. Modulation of kinin outflow from isolated perfused rat hearts by endothelin-1